KIRN DAVID (See Remarks) sold 7.7% of their position (69.08K shares) of 4D MOLECULAR THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.09M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/21/2026ACC: 0001193125-26-361096
DirectorOfficer10% Owner· See Remarks
Since Dec 2020
-69.08K
Net shares
Net seller
$1.09M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
50K acquired · 119.08K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+50K
Price / share
$4.14
Trade value
$207K
% of position
5.9%
8/19/2026
844.89K→894.89K
Common Stock
Direct
Shares
−43.15K
Price / share
$15.36
Trade value
$662.62K
% of position
4.8%
8/19/2026
894.89K→851.75K
Common Stock
Direct
Shares
−25.93K
Price / share
$16.42
Trade value
$425.65K
% of position
3.0%
8/19/2026
851.75K→825.82K
Total
Net shares
−19.08K
Net value
-$881.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/19/2026 | M · Option Exercise | +50K | $4.14 | $207K | 5.9% | 844.89K | 894.89K |
| Common Stock Direct | 8/19/2026 | S · Sale | −43.15K | $15.36 | $662.62K | 4.8% | 894.89K | 851.75K |
| Common Stock Direct | 8/19/2026 | S · Sale | −25.93K | $16.42 | $425.65K | 3.0% | 851.75K | 825.82K |
| Total | −19.08K | -$881.27K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
4.14
Held after
217.50K
Exercisable
—
8/19/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock50K shares | 8/19/2026 | M · Option Exercise | −50K | 4.14 | — | 217.50K |